Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Share
LinkedIn
Twitter
November 9, 2020
Impel Neuropharma Announces FDA Submission of New Drug Application for INP104 for the Acute Treatment of Migraine